The company started life in 2015, when it was spun out of the Queensland University of Technology. QUT remains a shareholder. Vald was ranked 20th in the Deloitte Technology Fast 50 awards last year thanks to its revenue growing 350 per cent in the three years since 2018. Key summary:
IPO to raise around $25 million.
Backed by Ellerston Capital, Regal Funds Management and Perennial Value Management.
Brokers: Bell Porter and Morgans
Product: Vald has a number of products that measure human strength and flexibility
Customers: used by hundreds of sports teams around the world, including every team in the English Premier League.
Additional potential: Vald’s products can also be applied in physiotherapy clinics and hospitals, to help with things like rehabilitation. It has more than 200 health-sector clients, but is keen to grow that side of the business.
